Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | EDNRB | P24530 | 1/20 | 0.33 |
| ▸ | EDNRA | P25101 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29430507 | 0.80 | FABP5 (0.48) | TSHR | |
| SCHEMBL789074 | 0.80 | FABP5 (0.48) | TSHR | |
| SCHEMBL6206197 | 0.75 | TSHR (0.48) | TSHRRNASEH1MAPTEDNRBEDNRA | |
| SCHEMBL1934695 | 0.72 | MCL1 (0.46) | POLBMAPTALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL28851009 | 0.70 | MCL1 (0.45) | POLBMAPTALDH1A1 | |
| SCHEMBL1660941 | 0.70 | HPGD (0.49) | CHRM2CHRM1CHRM3ALDH1A1 | |
| SCHEMBL28536408 | 0.69 | POLB (0.39) | POLBSLC6A4SLC6A3TSHREDNRB | |
| SCHEMBL7099567 | 0.69 | KMT2A (0.43) | TSHRCHRM2CHRM1CHRM3ALDH1A1 | |
| SCHEMBL27777776 | 0.69 | POLB (0.53) | POLBSLC6A4SLC6A3TSHRMAPT | |
| SCHEMBL789025 | 0.68 | PNMT (0.42) | RNASEH1MAPTKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7662960-B2 | Beta-strand mimetics and method relating thereto | CHOONGWAE PHARMA CORPORATION (KR) | 2010-02-16 | — | — | US | disclosed |
| EP-1646633-B1 | BETA-STRAND MIMETICS | CHOONGWAE PHARMA CORP (KR) | 2009-04-15 | — | — | EP | disclosed |
| EP-1646633-A1 | BETA-STRAND MIMETICS AND METHOD RELATING THERETO | Choongwae Pharma Corporation (KR) | 2006-04-19 | — | — | EP | disclosed |
| WO-2004108731-A1 | BETA-STRAND MIMETICS AND METHOD RELATING THERETO | CHOONGWAE PHARMA CORPORATION (KR) | 2004-12-16 | — | — | WO | disclosed |
| US-20040053331-A1 | Beta-strand mimetics and method relating thereto | CHOONGWAE PHARMA CORPORATION (KR) | 2004-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040053331-A1 | Beta-strand mimetics and method relating thereto | BIRC5, BIRC7, XIAP | POLB 179/4885SLC6A4 4062/4885SLC6A3 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.